Matches in Wikidata for { <http://www.wikidata.org/entity/Q58580490> ?p ?o ?g. }
- Q58580490 description "artículu científicu" @default.
- Q58580490 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58580490 description "scholarly article by Anna B Halpern et al published 8 November 2018 in Haematologica" @default.
- Q58580490 description "wetenschappelijk artikel" @default.
- Q58580490 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58580490 name "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 name "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 type Item @default.
- Q58580490 label "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 label "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 altLabel "Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms" @default.
- Q58580490 prefLabel "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 prefLabel "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 P1433 Q58580490-FC5B15DC-5627-46B6-9FB7-D43DEF38A250 @default.
- Q58580490 P1476 Q58580490-29177564-9E97-41DB-99DE-319847252567 @default.
- Q58580490 P2093 Q58580490-009C6158-8D0E-433F-881B-D1EEDDB63720 @default.
- Q58580490 P2093 Q58580490-1026634A-6C87-4CA9-B9FD-047834B01E6E @default.
- Q58580490 P2093 Q58580490-3EE76669-872C-492A-BE64-1C988812F8A2 @default.
- Q58580490 P2093 Q58580490-43338550-E10A-43CB-B4E3-03BB0006F3B9 @default.
- Q58580490 P2093 Q58580490-4498D802-627C-4260-AB13-A7EFFED4CE52 @default.
- Q58580490 P2093 Q58580490-46C9F31A-E9DE-4E06-9DA9-73DD3AD6F780 @default.
- Q58580490 P2093 Q58580490-4955C67E-1B4F-4CEE-9BB0-49BC435EF640 @default.
- Q58580490 P2093 Q58580490-77345316-7CA3-4D1E-A522-A56C02651908 @default.
- Q58580490 P2093 Q58580490-8900E85D-0AF5-4267-B9F1-462C9388BA79 @default.
- Q58580490 P2093 Q58580490-933096DD-6B91-4755-9728-973FB248D129 @default.
- Q58580490 P2093 Q58580490-A0BFB263-E906-4173-8F3B-AAC43748CF7F @default.
- Q58580490 P2093 Q58580490-A95AD903-DF0B-48F3-9E6E-D32E6F328883 @default.
- Q58580490 P2093 Q58580490-AD955E43-FBF2-4DC2-9CEC-73B3C7B890F4 @default.
- Q58580490 P2093 Q58580490-B30DB808-73F1-4AF3-B02E-8B7BF6B16191 @default.
- Q58580490 P2093 Q58580490-DA7303C9-F793-4EDA-B16B-C738D8B6D005 @default.
- Q58580490 P2093 Q58580490-E3F657DF-E408-40B3-A3DE-4191BF112C0A @default.
- Q58580490 P2860 Q58580490-2ED7E6E0-EA1E-4399-9448-1E296726C965 @default.
- Q58580490 P2860 Q58580490-32B7D5B6-83E1-4C83-866B-05C39DAF3EB2 @default.
- Q58580490 P2860 Q58580490-38C02C81-586C-4398-B521-98561FFF09DF @default.
- Q58580490 P2860 Q58580490-55C1B81C-05F2-4639-92CA-A5680CC93243 @default.
- Q58580490 P2860 Q58580490-675FFCC7-D0B3-4858-9D9B-44F752889287 @default.
- Q58580490 P2860 Q58580490-88FA7AC8-DFF8-4F77-A59D-36628DD65A6E @default.
- Q58580490 P2860 Q58580490-A22EB251-FDC4-45C6-97FB-D72D8E55CF13 @default.
- Q58580490 P2860 Q58580490-C2CAC028-2105-4A4B-B53F-F3D5AD07BBB1 @default.
- Q58580490 P2860 Q58580490-CA7DEAEF-D243-4079-A64D-BB5DC0CA61C9 @default.
- Q58580490 P2860 Q58580490-D047C1E0-591E-4B07-B6D9-5803D648639A @default.
- Q58580490 P2860 Q58580490-E1806AE0-0E53-4CF6-A97F-3E1FAB1BCAFA @default.
- Q58580490 P304 Q58580490-3C8761F5-A769-4654-AD70-C650376A259F @default.
- Q58580490 P31 Q58580490-01E88CAE-0529-4EC0-B1B8-00AE6BCA2453 @default.
- Q58580490 P356 Q58580490-C37571E0-B6C6-4F10-9722-ABB9317BB81D @default.
- Q58580490 P407 Q58580490-F8E24EAE-AA1E-4462-88F9-CEE7A2475188 @default.
- Q58580490 P433 Q58580490-7A52FF70-C4A6-4607-9096-2091B20166FB @default.
- Q58580490 P478 Q58580490-B68C9D26-9B07-43B2-917D-06DC62D71CD1 @default.
- Q58580490 P50 Q58580490-7DA0ACE7-D8B6-486D-A650-702C0BF19BC3 @default.
- Q58580490 P50 Q58580490-EE5CB1B4-0AE2-47AA-A678-8811113C72BE @default.
- Q58580490 P577 Q58580490-AACB36C7-7474-423A-9AA1-616BDB225B5F @default.
- Q58580490 P698 Q58580490-0C819A50-E1EE-4568-85EF-99E2D0AB08DF @default.
- Q58580490 P921 Q58580490-04AE239F-3D2F-4FAE-9588-F4DFD6A481E3 @default.
- Q58580490 P921 Q58580490-1C73D19C-9040-4D81-8FB3-814D5157EC60 @default.
- Q58580490 P921 Q58580490-50E739AA-F43B-4A94-B4A3-DC4C33117D95 @default.
- Q58580490 P921 Q58580490-AF7601C8-04D4-44D8-B40B-B3EE5F9EE6DF @default.
- Q58580490 P921 Q58580490-B899B5B0-0517-4DD2-94CC-808123006888 @default.
- Q58580490 P932 Q58580490-DDBF84EA-C4BA-4564-991D-C8A049B4FF61 @default.
- Q58580490 P356 HAEMATOL.2018.204792 @default.
- Q58580490 P698 30409798 @default.
- Q58580490 P1433 Q5638209 @default.
- Q58580490 P1476 "Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms" @default.
- Q58580490 P2093 "Anna B Halpern" @default.
- Q58580490 P2093 "Asma Anwar" @default.
- Q58580490 P2093 "Bart L Scott" @default.
- Q58580490 P2093 "Emily M Huebner" @default.
- Q58580490 P2093 "Heather A Smith" @default.
- Q58580490 P2093 "Johnnie J Orozco" @default.
- Q58580490 P2093 "Kaysey F Orlowski" @default.
- Q58580490 P2093 "Kelda M Gardner" @default.
- Q58580490 P2093 "Mary-Elizabeth M Percival" @default.
- Q58580490 P2093 "Pamela S Becker" @default.
- Q58580490 P2093 "Paul C Hendrie" @default.
- Q58580490 P2093 "Roland B Walter" @default.
- Q58580490 P2093 "Ryan D Cassaday" @default.
- Q58580490 P2093 "Sarah A Buckley" @default.
- Q58580490 P2093 "Tara L Chen" @default.
- Q58580490 P2093 "Vivian G Oehler" @default.
- Q58580490 P2860 Q34612117 @default.
- Q58580490 P2860 Q34612121 @default.
- Q58580490 P2860 Q35565648 @default.
- Q58580490 P2860 Q36806921 @default.
- Q58580490 P2860 Q37392513 @default.
- Q58580490 P2860 Q38410718 @default.
- Q58580490 P2860 Q40055082 @default.
- Q58580490 P2860 Q40985601 @default.
- Q58580490 P2860 Q41961502 @default.
- Q58580490 P2860 Q80189855 @default.
- Q58580490 P2860 Q88548733 @default.
- Q58580490 P304 "e143-e146" @default.
- Q58580490 P31 Q13442814 @default.
- Q58580490 P356 "10.3324/HAEMATOL.2018.204792" @default.
- Q58580490 P407 Q1860 @default.
- Q58580490 P433 "4" @default.
- Q58580490 P478 "104" @default.
- Q58580490 P50 Q75025967 @default.
- Q58580490 P50 Q96145785 @default.
- Q58580490 P577 "2018-11-08T00:00:00Z" @default.
- Q58580490 P698 "30409798" @default.
- Q58580490 P921 Q103824 @default.